Treatment
Taha Azad, PhD
Department of Microbiology and Infectiology
New therapeutic strategies (oncolytic viruses) to treat aggressive brain cancers in children, and new biosensors to study the interactions between PD-1 and PD-L1.
Mathieu Belzile, MD, DMD, FRCSC
Department of Surgery, Division of Otorhinolaryngology and Head and Neck Surgery
Otorhinolaryngologist (ENT) and cervico-facial surgeon specialized in cervico-facial oncology and microvascular reconstruction (head and neck cancers).
Paul Bessette, MD
Department of Obstetrics-Gynecology, Division of Gynecological Oncology
Gynecological oncologist specialized in antiangiogenic and response-modifying agents for the treatment of gynecological cancers.
Nicole Bouchard, MD, FRCPC
Department of Medicine, Division of Pulmonology
Pulmonologist specialized in pulmonary oncology (clinical studies).
Josée Brossard, MD
Department of Pediatrics, Division of Pediatric Hemato-Oncology
Pediatric hemato-oncologist specialized in the treatment of children with cancer (clinical and translational studies).
Janie Charlebois, MD
Department of Pediatrics, Division of Pediatric Hemato-Oncology
Pediatric hemato-oncologist specialized in the treatment of children with cancer (clinical studies).
Yves Collin, MD, FRCSC
Department of Surgery, Division of General Surgery
Hepatobiliary and pancreatic oncology surgeon specialized in procedure quality, prevention of perioperative infections and postoperative pain, predictors of metastatic recurrence, and access to surgery in disadvantaged environments.
Nathalie Faucheux, PhD
Department of Chemical and Biotechnological Engineering
Modulation of the biomechanics of cells adhering to the surface of biomimetic materials to direct them toward proliferation, differentiation or apoptosis (peptides derived from growth factors, self-assembled surfaces, controlled release systems).
David Fortin, MD, CSPQ, FRCSC
Department of Surgery, Division of Neurosurgery
Neurosurgeon and neuro-oncologist specialized in opening the blood-brain barrier, delivery of molecules to the central nervous system, chemoresistance related to the expression of efflux pumps in the blood-brain barrier and glial cells, and functional and anatomical brain imaging.
Laurent Fradet, MD, FRCSC
Department of Surgery, Division of Otorhinolaryngology and Head and Neck Surgery
Otorhinolaryngologist (ENT) and cervico-facial surgeon specialized in cervico-facial oncology and microvascular reconstruction (head and neck cancers).
Fernand Gobeil Junior, PhD
Department of Pharmacology-Physiology
Use of kinin analogues, to facilitate specific drug access to the brain, and kinin B1 receptor antagonists, in combination with chemotherapeutic agents to prevent the growth of triple-negative breast cancer. Expression, localization and functional correlation of G protein–coupled receptors in cancer.
Claudio Jeldres, MD, FRCSC
Department of Surgery, Divison of Urology
Urologic oncologist specialized in the treatment of urological cancers.
Marilyne Labrie, PhD
Department of Immunology and Cellular Biology
Development of personalized therapies for patients with breast or gynecological cancers (ovarian, endometrial) aimed at overcoming adaptive resistance to treatment.
Pierre Lavigne, PhD
Department of Biochemistry and Functional Genomics
Development of c-Myc inhibitors, and structural biology of Miz-1, the START domains of G protein-coupled receptors, and pro-urotensin-II.
Richard Leduc, PhD
Department of Pharmacology-Physiology
Structure-activity of plasma membrane pharmacological targets (G protein–coupled receptors and type II transmembrane serine proteases).
Frédéric Lemay, MD, FRCPC
Department of Medicine, Division of Gastroenterology
Gastrointestinal oncologist specialized in digestive oncology clinical trials, medical co-leader of the Phase 1 Oncology Unit (partnership between the IRCUS, the Hemato-Oncology Division of CIUSSS de l’Estrie-CHUS and the CRCHUS).
Laurence Masson-Côté, MD, FRCPC
Department of Nuclear Medicine and Radiobiology, Division of Radio-oncology
Radiation oncologist specialized in radiotherapy treatments for breast cancer and brain tumours.
David Mathieu, MD, FRCSC
Department of Surgery, Division of Neurosurgery
Neurosurgeon specialized in gamma knife radiosurgery (focused radiation) for the treatment of tumoral (brain metastases, glial tumours), vascular and functional brain pathologies
Mélanie Morin, PhD
School of Rehabilitation
Development of treatments, such as physiotherapy and laser, for disorders of the female urogenital system following oncological treatment (pain, sexual dysfunctions, incontinence, trauma, imaging, diagnostic methods, muscle).
Maxime Noël-Lamy, MD, FRCPC
Department of Diagnostic Radiology
Interventional radiologist specialized in ablative treatment of renal cell carcinoma, ablative treatment, chemoembolization and radioembolization of hepatocellular carcinoma, embolization treatment of neuroendocrine tumours metastatic to the liver, and local control of oligometastatic disease in other cancers.
Ayman Oweida, PhD
Department of Nuclear Medicine and Radiobiology
Effect of radiation on the tumour microenvironment and strategies to reduce the negative effects of radiation on tumour progression and metastasis.
Mathieu Quesnel-Vallières, PhD
Department of Immunology and Cellular Biology
Molecular profiling of cancer by high-throughput sequencing and study of the regulation of alternative RNA splicing.
Sébastien Rodrigue, PhD
Department of Biology
Innovative technologies for systems biology, synthetic biology and single-cell genomics.
Étienne Rousseau, MD, FRCPC
Department of Nuclear Medicine and Radiobiology, Division of Nuclear Medicine
Nuclear medicine physician specialized in theranostics, metabolic and functional imaging, medical image processing, development of methods for quantitative assessment of response to anti-tumour agents using functional imaging, nuclear medicine, positron emission tomography (PET).
Léon Sanche, PhD
Department of Nuclear Medicine and Radiobiology
Damage to the molecular constituents of cells by secondary particles generated by ionizing radiation, effects of low-energy secondary electrons.
Robert Sabbagh, MD, FRCPC
Department of Surgery, Division of Urology
Urologist specialized in the surgical treatment of urological cancers and in uro-oncology clinical studies to provide treatment for cancer patients.
Lee Hwa Tai, PhD
Department of Immunology and Cellular Biology
Mechanisms by which innate immune cells modulate the tumour microenvironment and promote tumour metastasis in the postoperative period, postoperative immune suppression by combining new immunotherapies and standard treatments.
Guy-Anne Turgeon, MD
Department of Nuclear Medicine and Radiobiology, Division of Radio-oncology
Radiation oncologist specialized in clinical and translational studies in radiation oncology.
Stéphanie Vairy, MD
Department of Pediatrics, Division of Pediatric Hemato-Oncology
Pediatric hemato-oncologist specialized in the treatment of children with cancer (clinical and translational studies).
Patrick Vermette, PEng, PhD
Department of Chemical and Biotechnological Engineering
Design and certification of medical devices (3D printing, surgical bioadhesive), tissue engineering and biomaterials (decellularization of organs and tissues for oncology applications, including an autologous liver graft), angiogenesis, biosensors, bioreactors and biomanufacturing.
Mathieu Viau, MD, FRCPC
Department of Obstetrics-Gynecology
Gynecological oncologist specialized in the treatment of cancers of the reproductive system (endometrium and ovaries).
